Anoikis is a kind of programmed cell death that is triggered when cells lose contact with each other or with the matrix. However, the potential value of anoikis-related genes (ARGs) in keloid (KD) has not been investigated.
Approach:
We downloaded three keloid fibroblast (KF) RNA sequencing (RNA-seq) datasets from the Gene Expression Omnibus (GEO) and obtained 338 ARGs from a search of the GeneCards database and PubMed articles. Weighted correlation network analysis was used to construct the coexpression network and obtain the KF-related ARGs. The LASSO–Cox method was used to screen the hub ARGs and construct the best prediction model. Then, GEO single-cell sequencing datasets were used to verify the expression of hub genes. We used whole RNA-seq for gene-level validation and the correlation between KD immune infiltration and anoikis.
Results:
Our study comprehensively analyzed the role of ARGs in KD for the first time. The least absolute shrinkage and selection operator (LASSO) regression analysis identified six hub ARGs (HIF1A, SEMA7A, SESN1, CASP3, LAMA3, and SIK2). A large number of miRNAs participate in the regulation of hub ARGs. In addition, correlation analysis revealed that ARGs were significantly correlated with the infiltration levels of multiple immune cells in patients with KD.
Innovation:
We explored the expression characteristics of ARGs in KD, which is extremely important for determining the molecular pathways and mechanisms underlying KD.
Conclusions:
This study provides a useful reference for revealing the characteristics of ARGs in the pathogenesis of KD. The identified hub genes may provide potential therapeutic targets for patients. This study provides new ideas for individualized therapy and immunotherapy.
Get full access to this article
View all access options for this article.
References
1.
MukhopadhyayA, DoDV, OngCT, et al.The role of stem cell factor and c-KIT in keloid pathogenesis: Do tyrosine kinase inhibitors have a potential therapeutic role? Br J Dermatol, 2011; 164(2):372–386; doi: 10.1111/j.1365-2133.2010.10035.x
2.
IqbalSA, SidgwickGP, BayatA. Identification of fibrocytes from mesenchymal stem cells in keloid tissue: A potential source of abnormal fibroblasts in keloid scarring. Arch Dermatol Res, 2012; 304(8):665–671; doi: 10.1007/s00403-012-1225-5
3.
OgawaR. Surgery for scar revision and reduction: From primary closure to flap surgery. Burns Trauma, 2019; 7:7; doi: 10.1186/s41038-019-0144-5
4.
MamalisAD, Lev-TovH, NguyenDH, et al.Laser and light-based treatment of Keloids–A review. J Eur Acad Dermatol Venereol, 2014; 28(6):689–699; doi: 10.1111/jdv.12253
5.
LiuT, MaX, OuyangT, et al.Efficacy of 5-aminolevulinic acid-based photodynamic therapy against keloid compromised by downregulation of SIRT1-SIRT3-SOD2-mROS dependent autophagy pathway. Redox Biol, 2019; 20:195–203; doi: 10.1016/j.redox.2018.10.011
6.
ChenD, YiR, HongW, et al.Anoikis resistance of small airway epithelium is involved in the progression of chronic obstructive pulmonary disease. Front Immunol, 2023; 14:1155478; doi: 10.3389/fimmu.2023.1155478
7.
MichelJB. Anoikis in the cardiovascular system: Known and unknown extracellular mediators. Arterioscler Thromb Vasc Biol, 2003; 23(12):2146–2154; doi: 10.1161/01.Atv.0000099882.52647.E4
8.
LiQ, ZhangH, HuJ, et al.Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients. Front Pharmacol, 2023; 14:1124262; doi: 10.3389/fphar.2023.1124262
9.
ZhangT, WangB, SuF, et al.TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR. Int J Biol Sci, 2022; 18(11):4560–4577; doi: 10.7150/ijbs.69933
10.
AdeshakinFO, AdeshakinAO, AfolabiLO, et al.Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming. Front Oncol, 2021; 11:626577; doi: 10.3389/fonc.2021.626577
11.
ZhuZ, FangC, XuH, et al.Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future. Front Oncol, 2022; 12:976557; doi: 10.3389/fonc.2022.976557
12.
WangJ, LuoZ, LinL, et al.Anoikis-associated lung cancer metastasis: Mechanisms and therapies. Cancers (Basel), 2022; 14(19); doi: 10.3390/cancers14194791
13.
GiancottiFG. Integrin signaling: Specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol, 1997; 9(5):691–700; doi: 10.1016/s0955-0674(97)80123-8
14.
YinJ, WangJ, ZhangX, et al.A missing piece of the puzzle in pulmonary fibrosis: Anoikis resistance promotes fibroblast activation. Cell Biosci, 2022; 12(1):21; doi: 10.1186/s13578-022-00761-2
15.
KimBG, AnHJ, KangS, et al.Laminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer. Am J Pathol, 2011; 178(1):373–381; doi: 10.1016/j.ajpath.2010.11.028
16.
SmithJC, BooneBE, OpalenikSR, et al.Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol, 2008; 128(5):1298–1310; doi: 10.1038/sj.jid.5701149
17.
KangY, RohMR, RajaduraiS, et al.Hypoxia and HIF-1α regulate collagen production in keloids. J Invest Dermatol, 2020; 140(11):2157–2165; doi: 10.1016/j.jid.2020.01.036
18.
HahnJM, GlaserK, McFarlandKL, et al.Keloid-derived keratinocytes exhibit an abnormal gene expression profile consistent with a distinct causal role in keloid pathology. Wound Repair Regen, 2013; 21(4):530–544; doi: 10.1111/wrr.12060
19.
DiaoX, GuoC, LiS. Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma. Thorac Cancer, 2023; 14(3):320–330; doi: 10.1111/1759-7714.14766
20.
LangfelderP, HorvathS. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics, 2008; 9:559; doi: 10.1186/1471-2105-9-559
21.
ShannonP, MarkielA, OzierO, et al.Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res, 2003; 13(11):2498–2504; doi: 10.1101/gr.1239303
22.
ShimJ, OhSJ, YeoE, et al.Integrated analysis of single-cell and spatial transcriptomics in keloids: Highlights on fibrovascular interactions in keloid pathogenesis. J Invest Dermatol, 2022; 142(8):2128–2139.e11; doi: 10.1016/j.jid.2022.01.017
23.
DirederM, WielscherM, WeissT, et al.The transcriptional profile of keloidal Schwann cells. Exp Mol Med, 2022; 54(11):1886–1900; doi: 10.1038/s12276-022-00874-1
24.
HaoY, HaoS, Andersen-NissenE, et al.Integrated analysis of multimodal single-cell data. Cell, 2021; 184(13):3573–3587.e29; doi: 10.1016/j.cell.2021.04.048
25.
ZhangX, LanY, XuJ, et al.Cell marker: A manually curated resource of cell markers in human and mouse. Nucleic Acids Res, 2019; 47(D1):D721–D728; doi: 10.1093/nar/gky900
26.
AranD, LooneyAP, LiuL, et al.Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol, 2019; 20(2):163–172; doi: 10.1038/s41590-018-0276-y
27.
DengCC, HuYF, ZhuDH, et al.Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases. Nat Commun, 2021; 12(1):3709; doi: 10.1038/s41467-021-24110-y
28.
Solé-BoldoL, RaddatzG, SchützS, et al.Single-cell transcriptomes of the human skin reveal age-related loss of fibroblast priming. Commun Biol, 2020; 3(1):188; doi: 10.1038/s42003-020-0922-4
29.
PhilippeosC, TelermanSB, OulèsB, et al.Spatial and single-cell transcriptional profiling identifies functionally distinct human dermal fibroblast subpopulations. J Invest Dermatol, 2018; 138(4):811–825; doi: 10.1016/j.jid.2018.01.016
30.
NewmanAM, LiuCL, GreenMR, et al.Robust enumeration of cell subsets from tissue expression profiles. Nat Methods, 2015; 12(5):453–457; doi: 10.1038/nmeth.3337
31.
XiaY, WangY, ShanM, et al.Decoding the molecular landscape of keloids: New insights from single-cell transcriptomics. Burns Trauma, 2023; 11:tkad017; doi: 10.1093/burnst/tkad017
32.
WangZC, ZhaoWY, CaoY, et al.The roles of inflammation in keloid and hypertrophic scars. Front Immunol, 2020; 11:603187; doi: 10.3389/fimmu.2020.603187
33.
JinSE, KimCK, KimYB. Cellular delivery of cationic lipid nanoparticle-based SMAD3 antisense oligonucleotides for the inhibition of collagen production in keloid fibroblasts. Eur J Pharm Biopharm, 2012; 82(1):19–26; doi: 10.1016/j.ejpb.2012.05.015
34.
GriffinMF, desJardins-ParkHE, MascharakS, et al.Understanding the impact of fibroblast heterogeneity on skin fibrosis. Dis Model Mech, 2020; 13(6); doi: 10.1242/dmm.044164
35.
UittoJ, PerejdaAJ, AbergelRP, et al.Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci U S A, 1985; 82(17):5935–5939; doi: 10.1073/pnas.82.17.5935
AshrafizadehM, MohammadinejadR, TavakolS, et al.Autophagy, anoikis, ferroptosis, necroptosis, and endoplasmic reticulum stress: Potential applications in melanoma therapy. J Cell Physiol, 2019; 234(11):19471–19479; doi: 10.1002/jcp.28740
38.
KakavandiE, ShahbahramiR, GoudarziH, et al.Anoikis resistance and oncoviruses. J Cell Biochem, 2018; 119(3):2484–2491; doi: 10.1002/jcb.26363
39.
González-LlorenteL, SantacatterinaF, García-AguilarA, et al.Overexpression of mitochondrial IF1 prevents metastatic disease of colorectal cancer by enhancing anoikis and tumor infiltration of NK cells. Cancers (Basel), 2019; 12(1); doi: 10.3390/cancers12010022
40.
WangYN, ZengZL, LuJ, et al.CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis. Oncogene, 2018; 37(46):6025–6040; doi: 10.1038/s41388-018-0384-z
41.
QinC, YangG, YangJ, et al.Metabolism of pancreatic cancer: Paving the way to better anticancer strategies. Mol Cancer, 2020; 19(1):50; doi: 10.1186/s12943-020-01169-7
42.
KhongmaneeA, LirdprapamongkolK, Tit-OonP, et al.Proteomic analysis reveals important role of 14-3-3σ in anoikis resistance of cholangiocarcinoma cells. Proteomics, 2013; 13(21):3157–3166; doi: 10.1002/pmic.201300219
43.
BeauséjourM, NoëlD, ThibodeauS, et al.Integrin/Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: Selective engagement and roles of PI3-K isoform complexes. Apoptosis, 2012; 17(6):566–578; doi: 10.1007/s10495-012-0713-6
44.
BeauséjourM, ThibodeauS, DemersMJ, et al.Suppression of anoikis in human intestinal epithelial cells: Differentiation state-selective roles of α2β1, α3β1, α5β1, and α6β4 integrins. BMC Cell Biol, 2013; 14:53; doi: 10.1186/1471-2121-14-53
45.
SethuramanA, BrownM, SeagrovesTN, et al.SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway. Breast Cancer Res, 2016; 18(1):81; doi: 10.1186/s13058-016-0738-9
46.
LinX, WangY, JiangY, et al.Sumoylation enhances the activity of the TGF-β/SMAD and HIF-1 signaling pathways in keloids. Life Sci, 2020; 255:117859; doi: 10.1016/j.lfs.2020.117859
47.
DescheneK, CélesteC, BoerboomD, et al.Hypoxia regulates the expression of extracellular matrix associated proteins in equine dermal fibroblasts via HIF1. J Dermatol Sci, 2012; 65(1):12–18; doi: 10.1016/j.jdermsci.2011.09.006
48.
RutherfordTR, ElderAM, LyonsTR. Anoikis resistance in mammary epithelial cells is mediated by semaphorin 7a. Cell Death Dis, 2021; 12(10):872; doi: 10.1038/s41419-021-04133-5
49.
BudanovAV, KarinM. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell, 2008; 134(3):451–460; doi: 10.1016/j.cell.2008.06.028
50.
KozakJ, WdowiakP, MaciejewskiR, et al.Interactions between microRNA-200 family and sestrin proteins in endometrial cancer cell lines and their significance to anoikis. Mol Cell Biochem, 2019; 459(1-2):21–34; doi: 10.1007/s11010-019-03547-2
51.
AkasakaY, IshikawaY, OnoI, et al.Enhanced expression of caspase-3 in hypertrophic scars and keloid: Induction of caspase-3 and apoptosis in keloid fibroblasts in vitro. Lab Invest, 2000; 80(3):345–357; doi: 10.1038/labinvest.3780039
52.
AiniW, XieL, HuW, et al.Exploration and identification of anoikis-related genes in polycythemia vera. Front Genet, 2023; 14:1139351; doi: 10.3389/fgene.2023.1139351
53.
EscateR, PadroT, BadimonL. LDL accelerates monocyte to macrophage differentiation: Effects on adhesion and anoikis. Atherosclerosis, 2016; 246(:177–186; doi: 10.1016/j.atherosclerosis.2016.01.002
54.
HuangC, ChenJ. Laminin?332 mediates proliferation, apoptosis, invasion, migration and epithelial?to?mesenchymal transition in pancreatic ductal adenocarcinoma. Mol Med Rep, 2021; 23(1); doi: 10.3892/mmr.2020.11649
CarpenterPM, ZiogasA, MarkhamEM, et al.Laminin 332 expression and prognosis in breast cancer. Hum Pathol, 2018; 82:289–296; doi: 10.1016/j.humpath.2018.08.003
57.
YangFC, TanBC, ChenWH, et al.Reversible acetylation regulates Salt-Inducible Kinase (SIK2) and its function in autophagy. J Biol Chem, 2013; 288(9):6227–6237; doi: 10.1074/jbc.M112.431239
58.
BonH, WadhwaK, SchreinerA, et al.Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer. Mol Cancer Res, 2015; 13(4):620–635; doi: 10.1158/1541-7786.Mcr-13-0182-t
59.
DaiXM, ZhangYH, LinXH, et al.SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases. Mol Oncol, 2021; 15(1):228–245; doi: 10.1002/1878-0261.12838
60.
LiY, YuJ, JiaM, et al.Salt-inducible kinase 2 functions as a tumor suppressor in hepatocellular carcinoma. Environ Toxicol, 2021; 36(12):2530–2540; doi: 10.1002/tox.23366
61.
OgawaR. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci, 2017; 18(3); doi: 10.3390/ijms18030606
62.
XuH, ZhuZ, HuJ, et al.Downregulated cytotoxic CD8(+) T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids. Cell Mol Immunol, 2022; 19(4):527–539; doi: 10.1038/s41423-021-00834-1
63.
WuJ, Del DucaE, EspinoM, et al.RNA Sequencing keloid transcriptome associates keloids with Th2, Th1, Th17/Th22, and JAK3-skewing. Front Immunol, 2020; 11:597741; doi: 10.3389/fimmu.2020.597741
64.
WangH, ZhouZ, LiuY, et al.Identification and validation of HOXD3 and UNC5C as molecular signatures in keloid based on weighted gene co-expression network analysis. Genomics, 2022; 114(4):110403; doi: 10.1016/j.ygeno.2022.110403
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
